https://www.selleckchem.com/pr....oducts/Nanchangmycin
However, currently available data do not support a causal relationship. We sought to examine whether depressive symptoms and level of Alzheimer's disease (AD) pathology are independently or interactively associated with the risk of progression to mild cognitive impairment (MCI). The study included a total of 216 participants from the Biomarkers for Older Controls at Risk for Alzheimer's Disease study, a cohort of individuals who were cognitively normal at baseline (mean age=57) and followed for more than 20 years (mean=12.7 years)
Like
Comment
Share
